Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma

Urology

Volumn 78, Issue 2, 2011, Pages 474.e1-474.e5

  Elwood, Hillary ^a,b,c,d   Chaux, Alcides ^a,b,c,d   Schultz, Luciana ^a,b,c,d   Illei, Peter B ^a,b,c,d   Baydar, Dilek E ^a,b,c,d   Billis, Athanase ^a,b,c,d   Sharma, Rajni ^a,b,c,d   Argani, Pedram ^a,b,c,d   Epstein, Jonathan I ^a,b,c,d   Netto, George J ^a,b,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BAF47; GENE PRODUCT; INI1 PROTEIN; MONOCLONAL ANTIBODY; SMARCB1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLLECTING DUCT CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

EID: 80051474212     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.04.043     Document Type: Article

References (24)

1. A. Lopez-Beltran, M. Scarpelli, and R. Montironi 2004 WHO classification of the renal tumors of the adults Eur Urol 49 2006 798 805
2. J.R. Srigley, and B. Delahunt Uncommon and recently described renal carcinomas Mod Pathol 22 suppl 2 2009 S2 S23
3. J.A. Biegel, J.Y. Zhou, and L.B. Rorke Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 1999 74 79 (Pubitemid 29062960)
4. I. Versteege, N. Sevenet, and J. Lange Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer Nature 394 1998 203 206 (Pubitemid 28325977)
5. C.W. Roberts, and J.A. Biegel The role of SMARCB1/INI1 in development of rhabdoid tumor Cancer Biol Ther 8 2009 412 416
6. E. Sigauke, D. Rakheja, and D.L. Maddox Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis Mod Pathol 19 2006 717 725
7. J.X. Cheng, M. Tretiakova, and C. Gong Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior Mod Pathol 21 2008 647 652 (Pubitemid 351744839)
8. J.L. Hornick, P. Dal Cin, and C.D. Fletcher Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma Am J Surg Pathol 33 2009 542 550
9. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
10. J.R. Srigley, and H. Moch Carcinoma of the collecting ducts of bellini J.N. Eble, G. Sauter, J.I. Sesterhenn Epstein, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Publishing Group Lyon 33 34
11. E. Craig, Z.K. Zhang, and K.P. Davies A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis EMBO J 21 2002 31 42 (Pubitemid 34087072)
12. A. Stojanova, and L.Z. Penn The role of INI1/hSNF5 in gene regulation and cancer Biochem Cell Biol 87 2009 163 177
13. E.M. Jackson, A.J. Sievert, and X. Gai Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors Clin Cancer Res 15 2009 1923 1930
14. I.L. de la Serna, Y. Ohkawa, and A.N. Imbalzano Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers Nat Rev Genet 7 2006 461 473 (Pubitemid 43780489)
15. C.J. Guidi, A.T. Sands, and B.P. Zambrowicz Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice Mol Cell Biol 21 2001 3598 3603 (Pubitemid 32381795)
16. A. Klochendler-Yeivin, L. Fiette, and J. Barra The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression EMBO Rep 1 2000 500 506
17. C.W. Roberts, S.A. Galusha, and M.E. McMenamin Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice Proc Natl Acad Sci U S A 97 2000 13796 13800
18. C.W. Roberts, M.M. Leroux, and M.D. Fleming Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5 Cancer Cell 2 2002 415 425 (Pubitemid 41039107)
19. M.S. Isakoff, C.G. Sansam, and P. Tamayo Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation Proc Natl Acad Sci U S A 102 2005 17745 17750 (Pubitemid 41803568)
20. C.G. Sansam, and C.W. Roberts Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation Cell Cycle 5 2006 621 624
21. J. Caramel, F. Quignon, and O. Delattre RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1 Cancer Res 68 2008 6154 6161
22. S. Medjkane, E. Novikov, and I. Versteege The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization Cancer Res 64 2004 3406 3413 (Pubitemid 38657912)
23. R. Albadine, L. Schultz, and P. Illei PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract Am J Surg Pathol 34 2010 965 969
24. A. Morozov, S.J. Lee, and Z.K. Zhang INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors Clin Cancer Res 13 2007 4721 4730 (Pubitemid 47294778)